November 16, 2021
Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People With Parkinson’s Disease
Two Yale Department of Psychiatry researchers have been awarded a $2 million grant from The Michael J. Fox Foundation for Parkinson’s Research to conduct the first clinical trial of ketamine to treat depression in people with Parkinson’s disease.